Leveraging proven microbial strains for bioproduction is a game changer. Working with us grants you access to an unparalleled high-performance strain platform and fermentation protocols optimized for multiple expression systems, significantly streamlining the production process for large-scale industrial applications.
OUR TECHNOLOGY
As global demand for dairy proteins soars and traditional production struggles to keep up, precision fermentation emerges as a revolutionary solution, ready to secure the future of our food supply with game-changing innovation.
WELCOME TO THE FOREFRONT
OF PRECISION FERMENTATION
Our bioproduction technology has been perfected for decades. We inherited our strains out of a license from Novozymes (today known as Novonesis), a global leader in biosolutions. There, talented R&D scientists have optimized the strains’ genomes to turn them into small but mighty production factories.
Our strains have been optimized for over 40 years and are already used to manufacture countless products on the market. Today, we continuously improve titers and processes, ensuring our customers to stay ahead of the market – long term.
At 21st.BIO, we take our customers from innovation to delivery.
OUR STRAIN ENGINEERING
Why settle for a pony if you can ride a Ferrari?
We know our strains inside out – and how to operate them. This dramatically speeds up development, with high titers obtained within months, and unmatched product stability. Decades of bioproduction expertise accelerates the development process considerably — from rapid screening and genetic engineering to establishing fermentation protocols, purification, DSP, and scaling up to industrial levels.
Expert strains, expert team
Together with Novozymes’ strains, we attracted many of the microbiologists, bioengineers and technicians who worked with them for most of their careers. Our scientists know these strains like they made them… because, well, they did! They’re microbial whisperers.
BEST TECH, REAL RESULTS
We have the world’s best technology, backed by several bioproduction milestones. But don’t just take our word for it — our results speak for themselves.
Here are some of our achievements:
World’s first extracellular expression of spider silk proteins — as part of our partnership with AMSilk.
Fastest path to market for our beta-lactoglobulin customers, with market entry under two years from the start of strain engineering.
From project initiation to first expression system in only a few months.
We are the precision fermentation launchpad. Our industrially proven technology platform leverages the most experienced production strains available. We accelerate the world’s quest for biosolutions – and make your innovations truly relevant.
PARTNER WITH US
CUSTOM DEVELOPMENT PROJECTS
Custom development projects are built on-demand to respond to our customer’s exact needs.
In this case, the project is individually designed to optimize your proprietary recombinant protein.
They can encompass a wide range of activities, including strain optimization, designing production and downstream processes, upscaling your production technology… Please contact our team for more information.
LET'S TALK
OUR DEVELOPMENT PROGRAMS
Our development programs enable the fast and cost-efficient industrial production of beta-lactoglobulin and caseins.
Capitalizing on our mature fungal production strain, these programs are offered to a limited number of companies who share the development costs. Participants are given a license to use our strain and processes.
Over time, 21st.BIO will continue to optimize the strain and processes, continuously keeping you ahead of the market.
ABOUT OUR DEVELOPMENT PROGRAMS
